The Fall 2024 Landmark College Academic Speakers Series concludes with a presentation by Dr. Michael Fricke entitled “Arsenic: The King of Poisons” on Wednesday, November 6 at 5 p.m. in the Brooks M. O Brien Auditorium/Lewis Academic Building.
The presentation will take a humanistic approach to the element, starting with the first occupational exposure to arsenic as Bronze Age smiths forged tools and weapons in their new smelters. Dr. Fricke will also discuss his work on the Tactile Periodic Table Project and advocacy for disabled chemists.
Michael Fricke, Ph.D. is an analytical development chemist at Olon Ricerca Bioscience based in Concord, Ohio and was the analytical lead for the development of molnupiravir, the first approved oral treatment for COVID-19. He is an expert on elemental impurities which developed from his graduate study of arsenic and led to an appointment as an Oak Ridge Post-Doctoral Fellow and then as a visiting scholar at the University of British Columbia. Dr Fricke is also a Councilor for the Akron Section of the American Chemical Society and is a member of the ACS Committee for Chemists with Disabilities.
This event is free and open to the public. For additional information or questions about venue accessibility, please contact Justine Gaskamp at justinegaskamp@landmark.edu.
Driving directions, a campus map, and more information about the Landmark College Academic Speaker Series are available at www.landmark.edu.